Company Filing History:
Years Active: 2020
Title: Zoltan Dekan: Innovator in Sodium Channel Modulation
Introduction
Zoltan Dekan is a prominent inventor based in Toowong, Australia. He has made significant contributions to the field of biochemistry, particularly in the area of sodium channel modulation. His innovative work focuses on utilizing peptides derived from spider venom for therapeutic applications.
Latest Patents
Zoltan Dekan holds a patent for "Spider venom peptides and methods of use for modulating sodium channels." This invention relates to peptides and their use for modulating sodium channels. More specifically, it involves peptides from the venom of tarantulas and their application in inhibiting Na1.7. This has potential implications for treating or preventing conditions associated with Na1.7 activity, such as neuropathic, inflammatory, and nociceptive pain. He has 1 patent to his name.
Career Highlights
Zoltan Dekan is affiliated with The University of Queensland, where he continues to advance research in his field. His work has garnered attention for its potential to revolutionize pain management therapies.
Collaborations
Zoltan has collaborated with notable researchers, including Paul Francis Alewood and Jennifer Deuis, enhancing the impact of his work through shared expertise.
Conclusion
Zoltan Dekan's innovative research on spider venom peptides represents a significant advancement in the modulation of sodium channels, with promising applications in pain management. His contributions to the field continue to inspire further research and development.